3’-Deoxy-3’-(18F) Fluorothymidine Positron Emission Tomography/Computed Tomography in Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy: A Pilot Study

3’-Deoxy-3’-(18F) Fluorothymidine Positron Emission Tomography/Computed Tomography in Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy: A Pilot Study

Purpose: The primary objective was to compare 3’-deoxy-3’-(18F) fluorothymidine (FLT) positron emission tomography (PET)/computed tomography (CT) uptake in 3 cohorts of stereotactic body radiation therapy (SBRT) patients: (1) pre-SBRT, (2) stable post-SBRT lung fibrosis, and (3) suspicious or proven...

Full description

Bibliographic Details
Main Authors: Shirley Lewis, MD, FRCR, Matthew Chan, MD, FRCPC, Jessica Weiss, PhD, Hamid Raziee, MD, FRCPC, Brandon Driscoll, MASc, Andrea Bezjak, MD, FRCPC, Alexander Sun, MD, FRCPC, Benjamin Lok, PhD, Douglass Vines, MRT, John Cho, PhD, Jean-Pierre Bissonnette, PhD, Srinivas Raman, MD, MASc, FRCPC, Andrew Hope, MD, FRCPC, Meredith Giuliani, MBBS, MEd, FRCPC
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109422001439

Internet

http://www.sciencedirect.com/science/article/pii/S2452109422001439

Similar Items